Fat embolism syndrome (FES) has been described in the literature as a rare complication of sickle cell disease (SCD). A review article published in 2005 reported 24 cases of FES associated with SCD. In many cases, a definitive diagnosis of FES in SCD is made on autopsy because of the lack of early recognition and the paucity of sensitive and specific testing for this syndrome. Patients with FES usually have a fulminant, rapidly deteriorating clinical course with mortality occurring within the first 24 hours. We postulate that FES is not well recognized in SCD and that FES scores are useful diagnostic tools in patients with SCD. We queried the electronic medical records with the diagnostic codes for SCD with acute chest syndrome (ACS), pulmonary embolism, or acute respiratory distress syndrome admitted to our hospital from 2008 to 2016 to identify patients suspected of having FES. In addition, we performed an extensive literature review to evaluate the management practice of pediatric patients with FES and SCD from 1966 to 2016. Six patients met our selection criteria from the hospital records, and 4 case reports from the literature search were also included. We applied the Gurd and Wilson criteria and the Schonfeld Fat Embolism Index to identify patients who met the criteria for FES. Nine patients fulfilled Gurd and Wilson criteria, and 9 patients who were evaluable met the Schonfeld criteria for FES. A rapidly deteriorating clinical course in a patient with SCD presenting with ACS or severe vaso-occlusive crisis should trigger a high index of suspicion for FES. Gurd and Wilson criteria or the Schonfeld Fat Embolism Index are useful diagnostic tools for FES in SCD.
PielFBHaySIGuptaSWeatherallDJWilliamsTN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484. doi:10.1371/journal.pmed.1001484.
2.
GhoshKColahRBMukherjeeMB. Haemoglobinopathies in tribal populations of India. Indian J Med Res. 2015;141(5):505–508. doi:10.4103/0971-5916.159488.
3.
QuinnCT. Sickle cell disease in childhood. Pediatr Clin North Am. 2013;60(6):1363–1381. doi:10.1016/j.pcl.2013.09.006.
4.
FaurouxBMullerMHQuinetBBéguéP. The sickle cell anemia lung from childhood to adulthood [in French]. Rev Mal Respir. 1998;15(2):159–168.
5.
MillerST. How I treat acute chest syndrome in children with sickle cell disease. Blood. 2011;117(20):5297–5305. doi:10.1182/blood-2010-11-261834.
6.
VichinskyEPNeumayrLDEarlesAN, et al.Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000;342(25):1855–1865. doi:10.1056/NEJM200006223422502.
AlobeidiFInusaBPDSinghRRU-King-ImJMLimM. Cerebral microhaemorrhages secondary to fat embolus syndrome in sickle cell disease. Postgrad Med J. 2015;91(1071):55–56. doi:10.1136/postgradmedj-2014-132984.
9.
DangNCJohnsonCEslami-FarsaniMHaywoodLJ. Bone marrow embolism in sickle cell disease: a review. Am J Hematol. 2005;79(1):61–67. doi:10.1002/ajh.20348.
10.
FabianTC. Unraveling the fat embolism syndrome. N Engl J Med. 1993;329(13):961–963. doi:10.1056/NEJM199309233291313.
11.
DesselleBCO’BrienTBugnitzMBeatyOWilimasJHeltonK. Fatal fat embolism in a patient with sickle-beta+ thalassemia. Pediatr Hematol Oncol. 1995;12(2):159–162.
TsitsikasDAGallinellaGPatelSSeligmanHGreavesPAmosRJ. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. Blood Rev. 2014;28(1):23–30. doi:10.1016/j.blre.2013.12.002.
14.
GurdARWilsonRI. The fat embolism syndrome. J Bone Joint Surg Br. 1974;56B(3):408–416.
15.
SchonfeldSAPloysongsangYDiLisioRCrissmanJDMillerEHammerschmidtDEJacobHS. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. 1983;99(4):438–443.
16.
RayburgMKalinyakKATowbinAJBakerPBJoinerCH. Fatal bone marrow embolism in a child with hemoglobin SE disease. Am J Hematol. 2010;85(3):182–184. doi:10.1002/ajh.21605.
17.
RaoSPDesaiNMillerST. B19 parvovirus infection and transient aplastic crisis in a child with sickle cell anemia. J Pediatr Hematol Oncol. 1996;18(2):175–177.
18.
AmmarJGhrairiHel MekkiFAissaIHamzaouiA. Acute chest syndrome during sickle cell disease: unusual etiology. Apropos of 3 cases with review of the literature[in French]. Tunis Med. 2003;81(5):345–350.
19.
RucknagelDL. The role of rib infarcts in the acute chest syndrome of sickle cell diseases. Pediatr Pathol Mol Med. 2001;20(2):137–154.
MilnerPFBrownM. Bone marrow infarction in sickle cell anemia: correlation with hematologic profiles. Blood. 1982;60(6):1411–1419.
24.
GarzaJA. Massive fat and necrotic bone marrow embolization in a previously undiagnosed patient with sickle cell disease. Am J Forensic Med Pathol. 1990;11(1):83–88.
25.
KolquistKAVnencak-JonesCLSwiftLPageDLJohnsonJEDenisonMR. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med. 1996;16(1):71–82.
26.
VichinskyEWilliamsRDasM, et al.Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994;83(11):3107–3112.
SteinPDBeemathAMeyersFASkafEOlsonRE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med. 2006;119(10):897.e7-e11. doi:10.1016/j.amjmed.2006.08.015.
NandiRVenkategowdaPMMutkuleDRaoSM. Fat embolism syndrome: case report of a clinical conundrum. J Anaesthesiol Clin Pharmacol. 2014;30(3):412–414. doi:10.4103/0970-9185.137281.
35.
KoulPAAhmadFGurcooSA, et al.Fat embolism syndrome in long bone trauma following vehicular accidents: experience from a tertiary care hospital in north India. Lung India. 2013;30(2):97–102. doi:10.4103/0970-2113.110413.
36.
ShapiroMPHayesJA. Fat embolism in sickle cell disease. Report of a case with brief review of the literature. Arch Intern Med. 1984;144(1):181–182.
LindequeBGSchoemanHSDommisseGFBoeyensMCVlokAL. Fat embolism and the fat embolism syndrome. A double-blind therapeutic study. J Bone Joint Surg Br. 1987;69 (1):128–131.
42.
BenoitPRHampsonLGBurgessJH. Value of arterial hypoxemia in the diagnosis of pulmonary fat embolism. Ann Surg. 1972;175(1):128–137.
43.
StylesLASchalkwijkCGAarsmanAJVichinskyEPLubinBHKuypersFA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996;87(6):2573–2578.
44.
BallasSKFilesBLuchtman-JonesL, et al.Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006;30(2):165–170. doi:10.1080/03630260600642260.
GodeauBSchaefferABachirD, et al.Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med. 1996;153(5):1691–1696. doi:10.1164/ajrccm.153.5.8630622.
47.
MimozOEdouardABeydonL, et al.Contribution of bronchoalveolar lavage to the diagnosis of posttraumatic pulmonary fat embolism. Intensive Care Med. 1995;21(12):973–980. doi:10.1007/BF01700658.
48.
NewbiginKSouzaCATorresC, et al.Fat embolism syndrome: state-of-the-art review focused on pulmonary imaging findings. Respir Med. 2016;113:93–100. doi:10.1016/j.rmed.2016.01.018.
49.
TakahashiMSuzukiROsakabeY, et al.Magnetic resonance imaging findings in cerebral fat embolism: correlation with clinical manifestations. J Trauma. 1999;46(2):324–327.
50.
RyuCWLeeDHKimTK, et al.Cerebral fat embolism: diffusion-weighted magnetic resonance imaging findings. Acta Radiol. 2005;46(5):528–533. doi:10.1080/02841850510021481.
FortenberryJDDel ToroJJeffersonLSEveyLHaaseD. Management of pediatric acute hypoxemic respiratory insufficiency with bilevel positive pressure (BiPAP) nasal mask ventilation. Chest. 1995;108(4):1059–1064.
53.
NeumayrLLennetteEKellyD, et al.Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112(1 pt 1):87–95.
54.
JohnsonKStastnyJFRucknagelDL. Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia. Am J Hematol. 1994;46(4):354–357.
55.
MorrisseyBJBycroftTPAlmossawiOWilkeyOBDanielsJG. Incidence and predictors of bacterial infection in febrile children with sickle cell disease. Hemoglobin. 2015;39(5):316–319. doi:10.3109/03630269.2015.1065419.
56.
FaurouxB. Respiratory distress and drepanocytosis[in French]. Arch Pediatr. 2000;7(suppl 1):82S–86S.
57.
CastroO. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am. 1996;10(6):1289–1303.
58.
MillerSTKimH-YWeinerD, et al.Inpatient management of sickle cell pain: a “snapshot” of current practice. Am J Hematol. 2012;87(3):333–336. doi:10.1002/ajh.22265.
59.
RadelEGKochenJAFinbergL. Hyponatremia in sickle cell disease. J Pediatr. 1976;88(5):800–805. doi:10.1016/S0022-3476(76)81118-3.
60.
HaynesJAllisonRC. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med. 1986;80(5):833–840.
61.
BuchananIDWoodwardMReedGW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr Blood Cancer. 2005;45(5):716–724. doi:10.1002/pbc.20403.
62.
BeiterJLSimonHKChamblissCRAdamkiewiczTSullivanK. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pediatr Adolesc Med. 2001;155(4):496–500.
63.
GuptaMMsambichakaLBallasSKGuptaK. Morphine for the treatment of pain in sickle cell disease. ScientificWorldJournal. 2015;2015:540154. doi:10.1155/2015/540154.
64.
NaikRPStreiffMBLanzkronS. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013;35(3):352–358. doi:10.1007/s11239-013-0895-y.
65.
OguanobiNIOnwubereBJCAnisiubaBCIkeSOEjimECIbegbulamOG. Clinical findings associated with cardiovascular autonomic dysfunction in adult sickle cell anaemia patients. Acta Cardiol. 2012;67(2):169–175. doi:10.2143/AC.67.2.2154207.
66.
SanyaEOSoladoyeAOlanrewajuTOKoloPMDurotoyeI. Cardiovascular autonomic reflex function in sickle cell anaemia patients. Niger Postgrad Med J. 2010;17(4):266–269.
67.
Romero MestreJCHernándezAAgramonteOHernándezP. Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death?Clin Auton Res. 1997;7(3):121–125.
68.
KuoKCornellTShanleyTOdetolaFAnnichG. The use of extracorporeal membrane oxygenation in pediatric patients with sickle cell disease. Perfusion. 2013;28(5):424–432. doi:10.1177/0267659113485873.
69.
TrantCACaseyJRHansellD, et al.Successful use of extracorporeal membrane oxygenation in the treatment of acute chest syndrome in a child with severe sickle cell anemia. ASAIO J. 1996;42(3):236–239.
70.
DangNCJohnsonCEslami-FarsaniMHaywoodLJ. Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival. Am J Hematol. 2005;80(2):133–136. doi:10.1002/ajh.20385.
